Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Multiple Sclerosis × Natalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Neoplasm Metastasis 1 Multiple Sclerosis, Chronic Progressive 1 Multiple Sclerosis 1 Multiple Myeloma 1

Interventions

fludarabine 2 Interferon beta-1b 2 Cyclophosphamide 2 nabiximols 1 Natalizumab 1 Mn-PyC3A 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01416181 2017-09-11

ASCEND in SPMS

Biogen

Phase 3 Terminated

889 enrolled 31 charts

Multiple Sclerosis, Neoplasm Metastasis, Multiple Sclerosis, Chronic Progressive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡